This result is consistent with previous findings which show that the knockdown of EGR4 significantly suppresses cancer cell growth rates in small cell lung cancer cells [22] and cholangiosarcoma cells [45], reduces cell viability and proliferation in non-small cell lung cancer cells, and reduces tumour growth using an in vivo mouse model [23]. The gene discussed is EGR4; the disease is non-small cell lung carcinoma.